Microcap Ledger Profusa, Inc. $PFSA
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Surgical & Medical Instruments & Apparatus
- Headquarters
- New York, NY
- Fiscal year end
- December 31
- Shares outstanding
- 605,647 [10-Q 2026-08-19]
What the company doesAI summary of filing
Profusa is a digital health technology company developing biosensor platforms for real-time monitoring of body chemistry. The company has developed the Lumee platform, which consists of subcutaneously injected hydrogel sensors paired with wearable optical readers and software algorithms. Lumee Oxygen has received CE approval in Europe for monitoring tissue oxygen in wound care and is planned for U.S. FDA submission in late 2026, while Lumee Glucose for continuous glucose monitoring is in clinical development with FDA approval targeted for late 2026 or early 2027. The company is currently pre-revenue in the U.S. market, with plans to commercialize first in Europe beginning in early 2026. [10-K 2026-04-15]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | — | −$12.21M | −$5.21M | $719.0K | [10-Q 2026-08-19] |
| FY ended Dec 2025 | — | −$35.82M | −$16.25M | $1.78M | [S-1/A 2026-05-01] |
| FY ended Dec 2024 | $100.0K | −$9.23M | −$2.07M | $191.0K | [S-1/A 2026-05-01] |
- Quarterly cash burn
- −$2.60M
- Cash runway Estimate
- ~0.8 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-12-17 | 5,881,269 | [10-Q 2024-12-17] |
| 2025-03-28 | 5,348,311 | [10-K 2025-03-31] |
| 2025-06-13 | 5,348,311 | [10-Q 2025-06-13] |
| 2025-08-12 | 32,788,877 | [10-Q 2025-08-14] |
| 2025-11-18 | 65,680,958 | [10-Q 2025-11-19] |
| 2026-04-14 | 4,410,268 | [10-K 2026-04-15] |
| 2026-05-13 | 4,660,268 | [10-Q 2026-05-15] |
| 2026-08-18 | 605,647 | [10-Q 2026-08-19] |
- Shelf registration
- S-1 filed 2026-04-28; declared effective 2026-05-04 [S-1 2026-04-28]
Listing status
Current status: 8 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-08-31. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-08-31 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-08-31] |
| 2026-04-29 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-04-29] |
| 2026-03-13 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-03-13] |
| 2025-11-03 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-11-03] |
| 2025-09-16 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-09-16] |
| 2024-12-26 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2024-12-26] |
| 2024-12-12 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2024-12-12] |
| 2024-10-21 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2024-10-21] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-08-21 | Knechtel Fred S. | other | 54,323 | — | [4 2026-09-04] |
| 2026-08-21 | Knechtel Fred S. | other | 301,991 | — | [4 2026-09-04] |
| 2026-08-21 | Stover Jack E | other | 32,018 | — | [4 2026-09-04] |
| 2026-08-21 | Stover Jack E | other | 301,991 | — | [4 2026-09-04] |
| 2026-08-17 | Hrt Financial Lp | sell | 18,395 | $5.94 | [4 2026-08-19] |
| 2026-08-14 | Hrt Financial Lp | sell | 3,163 | $0.90 | [4 2026-08-18] |
| 2026-08-13 | Hrt Financial Lp | sell | 42,411 | $0.89 | [4 2026-08-14] |
| 2026-08-12 | Knechtel Fred S. | other | 301,991 | $4.28 | [4 2026-08-19] |
| 2026-08-12 | Stover Jack E | other | 301,991 | $4.28 | [4 2026-08-19] |
| 2026-08-12 | Hrt Financial Lp | buy | 5,585 | $0.96 | [4 2026-08-14] |
| 2026-08-11 | Hrt Financial Lp | sell | 2,280 | $0.97 | [4 2026-08-12] |
| 2026-08-10 | Hrt Financial Lp | buy | 4,016 | $0.94 | [4 2026-08-12] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-09 | 8-K | Auditor change |
| 2026-10-05 | 8-K | Material agreement entered; New financial obligation |
| 2026-09-21 | 8-K | Shareholder vote results |
| 2026-09-16 | 8-K | Material agreement entered; New financial obligation |
| 2026-09-15 | 8-K | Other events |
| 2026-09-01 | 8-K | Material agreement entered; New financial obligation |
| 2026-08-31 | 8-K | Listing notice or transfer |
| 2026-08-28 | DEF 14A | Proxy statement |
| 2026-08-21 | 8-K | Material agreement entered; New financial obligation; Unregistered sale of equity |
| 2026-08-20 | 8-K | Results of operations |
| 2026-08-19 | 13D | Beneficial ownership report (5%+ holder) |
| 2026-08-19 | 10-Q | Quarterly report |
Alerts for $PFSA
Email me when Profusa, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.